Hefei Lifeon Pharmaceutical Co Ltd Total Liabilities
Hefei Lifeon Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Hefei Lifeon Pharmaceutical Co Ltd (003020) has total liabilities worth CN¥634.92 Million CNY (≈ $92.91 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 003020 financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Hefei Lifeon Pharmaceutical Co Ltd (2012–2025)
Total liabilities of Hefei Lifeon Pharmaceutical Co Ltd from 2012 to 2025. This chart illustrates how Hefei Lifeon Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data.
Hefei Lifeon Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Hefei Lifeon Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Allied Properties Real Estate Investment Trust
TO:AP-UN
|
Canada | CA$4.63 Billion |
|
HeNan Splendor Science & Technology Co Ltd
SHE:002296
|
China | CN¥802.43 Million |
|
AUPU Home Style Corp Ltd
SHG:603551
|
China | CN¥725.03 Million |
|
Qualipoly Chemical Corp
TW:4722
|
Taiwan | NT$3.60 Billion |
|
Taiwan Chinsan Electronic Industrial Co Ltd
TWO:8042
|
Taiwan | NT$4.89 Billion |
|
Sprout Social Inc
NASDAQ:SPT
|
USA | $293.41 Million |
|
PNE AG
XETRA:PNE3
|
Germany | €1.13 Billion |
|
Soulbrain Holdings Co. Ltd
KQ:036830
|
Korea | ₩710.86 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down Hefei Lifeon Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Hefei Lifeon Pharmaceutical Co Ltd total assets.
Liquidity & Leverage Metrics
Hefei Lifeon Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Hefei Lifeon Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.44 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hefei Lifeon Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hefei Lifeon Pharmaceutical Co Ltd (2012–2025)
The table below shows the annual total liabilities of Hefei Lifeon Pharmaceutical Co Ltd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥634.19 Million ≈ $92.80 Million |
-5.82% |
| 2024-12-31 | CN¥673.38 Million ≈ $98.54 Million |
+10.36% |
| 2023-12-31 | CN¥610.18 Million ≈ $89.29 Million |
-4.89% |
| 2022-12-31 | CN¥641.53 Million ≈ $93.88 Million |
+73.14% |
| 2021-12-31 | CN¥370.53 Million ≈ $54.22 Million |
+2.35% |
| 2020-12-31 | CN¥362.03 Million ≈ $52.98 Million |
+20.75% |
| 2019-12-31 | CN¥299.82 Million ≈ $43.87 Million |
+13.01% |
| 2018-12-31 | CN¥265.31 Million ≈ $38.82 Million |
+5.64% |
| 2017-12-31 | CN¥251.14 Million ≈ $36.75 Million |
+0.57% |
| 2016-12-31 | CN¥249.71 Million ≈ $36.54 Million |
-4.00% |
| 2014-12-31 | CN¥260.11 Million ≈ $38.06 Million |
-3.43% |
| 2013-12-31 | CN¥269.34 Million ≈ $39.41 Million |
+24.31% |
| 2012-12-31 | CN¥216.67 Million ≈ $31.71 Million |
-- |
About Hefei Lifeon Pharmaceutical Co Ltd
Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients in China and internationally. The company offers active pharmaceutical ingredients, which includes felodipine, urea, paeonol, doxazosin mesylate, prilocaine, nifedipine, azilsartan kamedoxomil, methylphenidate hydrochloride, dexmethy… Read more